1007-3639
2011 Issue 3
The influence of p53 gene 245 site mutation to human lung adenocarcinoma cell line H1299
WANG Rui;GONG Zhao-hua;JIANG Li-xin;SUN Deng-jun;JIAO Ai-hong;CHEN Jian;ZHANG Liang-ming
WANG Rui;GONG Zhao-hua;JIANG Li-xin;SUN Deng-jun;JIAO Ai-hong;CHEN Jian;ZHANG Liang-ming
..............page:177-181
Silencing ALKI expression inhibits cell growth in human gastric cancer cell line SGC-7901
CHEN Ling;LIANG Guang-ping;WANG Zong-hua;LI Xue-cheng;ZOU Li-quan;LIU Zhi-peng;XIONG Xiao-feng;ZHANG Fang-zheng
CHEN Ling;LIANG Guang-ping;WANG Zong-hua;LI Xue-cheng;ZOU Li-quan;LIU Zhi-peng;XIONG Xiao-feng;ZHANG Fang-zheng
..............page:182-186
Effects of antisense Oligonucleotide targeted hsa-miR-491-3p on biological properties of NCI-H446cells
GUAN Shi-zhen;FU Yu-rong;YI Zheng-jun;LI Meng;PEI Jing-liang;GAO Kun-Shan
GUAN Shi-zhen;FU Yu-rong;YI Zheng-jun;LI Meng;PEI Jing-liang;GAO Kun-Shan
..............page:171-176
The mechanisms of action of decitabine against Jeko-1 MCL cell line
GENG Mei;FEI Ai-mei;LIU Jing-jing;NIE Rui-min;WANG Jin;MI Jian-qing
GENG Mei;FEI Ai-mei;LIU Jing-jing;NIE Rui-min;WANG Jin;MI Jian-qing
..............page:161-166
Clinical significance and expression of C-FLIP in human non-melanocytic skin tumors
LIU Xiao-qing;TU Ya-ting
LIU Xiao-qing;TU Ya-ting
..............page:167-170
The relationship between the serum CEA level and the efficacy of EGFR-TKI treatment in non-small cell lung cancer patients
LI Xing-ya;CHENG Yuan;LIU Jie;SHEN Shu-jing;JIA Yong-xu
LI Xing-ya;CHENG Yuan;LIU Jie;SHEN Shu-jing;JIA Yong-xu
..............page:193-196
Comparative proteomic analysis of human osteosarcoma cell and primary cultured osteoblastic cell
LIU Xu-dong;ZENG Bing-fang
LIU Xu-dong;ZENG Bing-fang
..............page:187-192
Long-term efficacy of hyperfractionated intracavitary brachytherapy on 69 patients with locally recurrent nasopharyngeal carcinoma
TANG Tian-lan;XU Lu-ying;PAN Jian-ji;QIU Su-fang;CHEN Chuan-ben;LIN Shao-jun;ZHANG Chun;YANG Ling;NI Xiao-lei;YANG Bai-hua;WU Jun-xin
TANG Tian-lan;XU Lu-ying;PAN Jian-ji;QIU Su-fang;CHEN Chuan-ben;LIN Shao-jun;ZHANG Chun;YANG Ling;NI Xiao-lei;YANG Bai-hua;WU Jun-xin
..............page:201-206
The clinical value of serum VEGF and TRACP-5b as markers to diagnose bone metastases in lung carcinoma patients
MIN Hai-yan;LI Juan-juan;ZHANG Hang;QIAN Ke-qing;CEN Ling
MIN Hai-yan;LI Juan-juan;ZHANG Hang;QIAN Ke-qing;CEN Ling
..............page:197-200
Clinical efficacy of topotecan in the treatment of platinum-resistant palindromia ovarian cancer
REN Qing;XIONG Rui-hua;WANG Hong-zhi;ZHOU Xin
REN Qing;XIONG Rui-hua;WANG Hong-zhi;ZHOU Xin
..............page:207-210
The clinical study of bevacizumab combination with docetaxel in the treatment of metastatic Her-2 negative breast cancer patients
HUANG Hong-yan;JIANG Ze-fei;WANG Tao;ZHANG Shao-hua;BIAN Li;CAO Yang;WU Shi-kai;SONG San-tai
HUANG Hong-yan;JIANG Ze-fei;WANG Tao;ZHANG Shao-hua;BIAN Li;CAO Yang;WU Shi-kai;SONG San-tai
..............page:220-224
Retrospective study of gastrointestinal stromal tumor
GE Xiao-ming;SUN Xiao-guang;LIANG Zheng
GE Xiao-ming;SUN Xiao-guang;LIANG Zheng
..............page:217-219
Treatment and prognostic factors affecting on pancreatic cancer survival
DAI Yue-di;ZHANG De-xiang;YUAN Su-xu;TAO Li
DAI Yue-di;ZHANG De-xiang;YUAN Su-xu;TAO Li
..............page:211-216
Juvenile papillomatosis in patients younger than 30-year-old: a clinical analysis of 7 cases
WANG Tong;LIU Hong;YANG Jun-e
WANG Tong;LIU Hong;YANG Jun-e
..............page:228-231
Anastrozole combined with goserelin in pre-menopausal patients with hormone dependent breast cancer inclined to recurrence and metastasis
CHEN De-dian;HUANG Sheng;ZHOU Shao-qiang;CHEN Wen-lin;YANG Zhuang-qing;ZHANG Ji;NIE Jian-yun
CHEN De-dian;HUANG Sheng;ZHOU Shao-qiang;CHEN Wen-lin;YANG Zhuang-qing;ZHANG Ji;NIE Jian-yun
..............page:225-227
Recent progress in the research on the various origins of cancer stem cells and their relevant mechanisms
LIU Zeng-jun
LIU Zeng-jun
..............page:236-240
..............page:232-235